Explore the strengths and pitfalls of EBITDA. Understand how it differs from cash flow and its role in assessing a company's ...

MNTN, Inc. is rated a Hold, as shares trade at fair value, despite revenue growth and net income increase. Learn more about ...

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...

Discover why PARR stock faces risks from volatile margins & high costs. Learn about valuation concerns and why it’s rated a ...

ICICI Securities recommends a Buy on Orkla India, targeting ₹800, driven by strong market share and growth potential.

HONG KONG, Dec. 23, 2025 (GLOBE NEWSWIRE) -- J-Long Group Limited (“JL” or the “Company”) (NASDAQ: JL), JL conducts its primary operations of apparel trims solution services in Hong Kong, today ...

Learn how Cash Value Added (CVA) measures a company's cash flow exceeding investor returns, and how it compares to EVA and EBITDA in assessing profitability.

The debt-to-equity (D/E) ratio is an important measure to assess the financial structure and risk profile of a company.

In fiscal year 2026, we expect to generate $10 million in cost savings compared to fiscal year 2025. Importantly, Sunkist provides enhanced customer access to premium accounts and major US retailers ...

EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Indicated by a lower-than-industry-average EV/EBITDA ratio of 9.33, the company suggests a ...

ICICI Securities has initiated coverage on Orkla India stock with a 'Buy' rating and a target price of ₹800, on the back of ...

Simulations Plus, Inc. (NASDAQ:SLP) is one of the best healthcare AI stocks to buy now. On December 9, Simulations Plus, Inc.